Why Choose Us
At NewYork-Presbyterian, we treat all types and stages of lung cancer using a multidisciplinary approach. Our teams collaborate to provide the services you need, from prevention and early detection to high-risk assessment, genetic testing, and the latest treatments for advanced disease. We are home to two of the nation's leading cancer centers – the National Cancer Institute-designated Herbert Irving Comprehensive Cancer Center at New York-Presbyterian/Columbia University Irving Medical Center and Weill Cornell Medicine Meyer Cancer Center in partnership with NewYork-Presbyterian. We offer comprehensive cancer care at our hospitals in Westchester, Hudson Valley, Brooklyn, and Queens.
Our Lung Cancer Care Team
Our nationally renowned medical oncologists, thoracic surgeons, radiation oncologists, pathologists, oncology nurses, and respiratory therapists work together to provide you with a comprehensive, personalized treatment plan. They meet regularly to discuss your case, ensuring you receive the most effective lung cancer therapies. Our nutritionists, social workers, rehabilitation therapists, and palliative care experts will help you address the effects of lung cancer and its treatment on your physical and emotional well-being.
Our Approach to Lung Cancer Care
We treat all types and stages of lung cancer, including non-small cell carcinomas, small cell lung cancer, and mediastinal and pleural tumors, including thymoma and mesothelioma. Your treatment may include a combination of chemotherapy, targeted therapies, surgery, radiation therapy, and immunotherapy.
Before creating your treatment plan, we get to know you and learn about your cancer's type, stage, and location. We look at your tumor's genetic makeup and other factors that will influence the treatment choice.
Home to two major academic medical centers, we participate in clinical trials for all types of lung cancer. These studies offer access to investigational therapies that show promise for fighting cancer. Scientists in our laboratories also scrutinize the intricacies of lung cancer development and progression, helping to identify which novel therapies might offer better outcomes for our patients.
Lung cancer screening
Lung cancer screening aims to detect lung cancer in its earliest stages, before an individual experiences symptoms and when treatment is most effective. The National Lung Screening Trial demonstrated that annual screening with low-dose computed tomography (CT) can reduce lung cancer deaths in individuals at high risk for lung cancer by 20%, as opposed to chest x-ray screening. Our lung cancer screening programs offer state-of-the-art low-dose CT imaging interpreted by fellowship-trained experienced radiologists. Learn more about lung cancer screening at NewYork-Presbyterian.